Everpure (P) Chief Visionary Officer John Colgrove Sells 100,000 Shares Worth $11M

What Happened

• John Colgrove, Chief Visionary Officer and director of Everpure, sold 100,000 shares in open-market trades on Sept 21, 2026 for about $11.03 million (97,866 shares at a weighted avg $110.33 and 2,134 shares at a weighted avg $111.12). On Sept 20, 2026, 15,956 shares were withheld by the issuer to satisfy tax withholding in connection with vesting/net settlement of equity awards (value reported $1,661,658). The filing also reports a 100,000-share gift to The Colgrove Family Charitable Remainder Trust.

Key Details

• Transaction dates and prices:
  • 2026-09-20: 15,956 shares withheld for taxes at $104.14 (reported value $1,661,658) — not a sale by the insider (F1).
  • 2026-09-21: Gift of 100,000 shares to The Colgrove Family Charitable Remainder Trust (no cash proceeds) (F2, F3).
  • 2026-09-21: Open-market sales totaling 100,000 shares — 97,866 @ weighted avg $110.33 (sales range $110.00–$110.99) and 2,134 @ weighted avg $111.12 (sales range $111.00–$111.27); total proceeds ≈ $11,034,686 (F4–F6).
• Shares owned after the transactions: Not specified in the filing.
• Notable footnotes: tax-withholding/net settlement (F1); gift to charitable remainder trust (F2, F3); sales were effected under a Rule 10b5-1 plan adopted Jan 8, 2026 (F4); weighted-average price ranges disclosed (F5, F6). Other trusts (Colgrove Family Living Trust, EEC Irrevocable Trust, RWC Irrevocable Trust) are noted as holders (F7–F9).
• Filing timeliness: Filing dated 2026-09-22 for transactions on 9/20–9/21; no late filing is indicated.

Context

• The 15,956-share entry reflects shares withheld to satisfy tax withholding on a previously reported equity award (a net settlement), not an open-market sale by Colgrove. The 100,000-share gift was directed to a family charitable remainder trust and does not necessarily indicate market sentiment. The open-market sales were carried out under a pre-established Rule 10b5-1 trading plan, which is a common mechanism for scheduled insider sales.